Aricept and Medrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aricept (donepezil hydrochloride) and Medrol (methylprednisolone). Common drug interactions include dermatitis contact among females and post transplant lymphoproliferative disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Aricept and Medrol. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Aricept?

Aricept has active ingredients of donepezil hydrochloride. It is often used in alzheimer's disease. eHealthMe is studying from 24,756 Aricept users. Check the latest studies of Aricept.

What is Medrol?

Medrol has active ingredients of methylprednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 24,443 Medrol users. Check the latest studies of Medrol.



On Jul, 12, 2026

41 people who take Aricept and Medrol together, and have interactions are studied.

Aricept and Medrol drug interactions.

What are the common drug interactions of Aricept and Medrol, by gender? *:

female:

  1. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  2. Diastolic dysfunction
  3. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  4. Dysarthria (speech disorder)
  5. Dyslipidaemia (abnormal amount of lipids)
  6. Dyspepsia (indigestion)
  7. Dyspnoea exertional (breathlessness or shortness of breath)
  8. Embolic stroke (stroke due to obstruction due to an embolus)
  9. Emotional disorder
  10. Excoriation (to tear or wear off the skin of)

male:

  1. Post transplant lymphoproliferative disorder
  2. Dyspnoea (difficult or laboured respiration)
  3. Scrotal infection (infection in scrotum area)
  4. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  5. Anal abscess
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  8. Death
  9. Delirium (wild excitement)
  10. Gastroenteritis staphylococcal (inflammation of stomach and intestine caused by staphylococcal infection)

What are the common drug interactions of Aricept and Medrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  2. Nasopharyngitis (inflammation of the nasopharynx)

30-39:

  1. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)

40-49:

n/a

50-59:

  1. Gangrene (body tissue dies)
  2. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  3. Nerve injury
  4. Pain
  5. Rectal abscess (pus in rectum)
  6. Scar
  7. Scrotal infection (infection in scrotum area)
  8. Anal abscess

60+:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Asthenia (weakness)
  3. Loss of consciousness
  4. Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased)
  5. Abasia (inability to walk)
  6. Aphasia (damage to the parts of the brain that control language)
  7. Electrocardiogram qt prolonged
  8. Fatigue (feeling of tiredness)
  9. Haemorrhage intracranial (bleeding within the skull)
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

What are the existing conditions these people have? *

  1. Pain: 9 people, 21.95%
  2. Parkinson's Disease: 6 people, 14.63%
  3. Osteoporosis (bones weak and more likely to break): 6 people, 14.63%
  4. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 6 people, 14.63%
  5. High Blood Pressure: 5 people, 12.20%
  6. Insomnia (sleeplessness): 4 people, 9.76%
  7. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 9.76%
  8. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 7.32%
  9. Nausea (feeling of having an urge to vomit): 3 people, 7.32%
  10. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Aricept and Medrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aricept and Medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aricept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aricept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Medrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on donepezil hydrochloride and methylprednisolone (the active ingredients of Aricept and Medrol, respectively), and Aricept and Medrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: